NETRAMARK TO PRESENT NOVEL AI-BASED CLINICAL TRIAL TREATMENT ... - BioSpace

Retrieved on: 2025-02-18 22:36:08

Tags for this article:

Cybernetics

Artificial intelligence

Clinical trial

Machine learning

Schizophrenia

NetraMark Holdings Inc.

Click the tags to see associated articles and topics

NETRAMARK TO PRESENT NOVEL AI-BASED CLINICAL TRIAL TREATMENT ... - BioSpace. View article details on hiswai:

Summary

NetraMark Holdings Inc. utilizes generative AI and machine learning to enhance clinical trial analytics, specifically addressing patient heterogeneity in psychiatric disorders like schizophrenia. Tags like Cybernetics and Machine Learning highlight the innovative AI-driven approach for predictive modeling and patient stratification.

Article found on: www.biospace.com

View Original Article